Even though telehealth stocks carry the risk factor of the tech sector and other innovative stocks, the profit margin can be ...

In 2024, the Rx IP Update team at Smart & Biggar reported on a number of developments in Canadian life sciences IP and ...

Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...

Cancer screening is key to saving patients' lives, since an earlier stage diagnosis improves survival rates, decreases ...

Oncology drugs tend to “percolate to the top” of shortage lists that prioritize drugs of concern, said expert.

Wholesalers are vital in Canada’s economic network, connecting manufacturers with retailers and direct-to-consumer (D2C) businesses.